Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial. [PDF]
Zhao J +22 more
europepmc +1 more source
Racial differences in medication beliefs and adherence barriers among patients with systemic lupus erythematosus. [PDF]
Rangaswamy S +10 more
europepmc +1 more source
Urinary acetylated protein as a biomarker of lupus nephritis: a prospective cohort study. [PDF]
Lee YJ +10 more
europepmc +1 more source
Increased Tph cells are associated with disease activity and elevated plasma TGF-β1 levels in systemic lupus erythematosus. [PDF]
Wu C +8 more
europepmc +1 more source
RETRACTION: Identification of Novel Biomarkers for Childhood-Onset Systemic Lupus Erythematosus Using Machine Learning Algorithms and Immune Infiltration Analysis. [PDF]
europepmc +1 more source
Correction: Distribution of nailfold videocapillaroscopy parameters in systemic lupus erythematosus and their association with disease activity: an international blinded case-control analysis on behalf of the EULAR study group on microcirculation in rheumatic diseasesEffectiveness of ixekizumab in 709 real-world patients with axial spondyloarthritis and psoriatic arthritis: a nationwide cohort study. [PDF]
europepmc +1 more source
Correction for Zhao et al., Blood-labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus. [PDF]
europepmc +1 more source

